Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

462.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 485.00p
  • 52 Week Low: 327.50p
  • Currency: UK Pounds
  • Shares Issued: 47.52m
  • Volume: 9,521
  • Market Cap: £219.80m
  • RiskGrade: 180
  • Beta: 0.01

Tristel Overview

We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business.
Competitors: Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics

Key Personnel

CEO: Paul Christopher Swinney
Executive Director: Bart Leemans
Finance Director: Elizabeth Dixon
Independent Non-Executive Director: Caroline Stephens
Non-Executive Chairman: Bruno Holthof
Senior Independent Director: Isabel J S Napper
Non-Executive Dir: David Orr , Tom Jenkins

Contact Details

Address: Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY
Phone: 44 (0) 1638 721500
Fax: 44 (0) 1638 721911
Website: http://www.tristel.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B07RVT99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 462.50p
Change Today -2.50p
% Change -0.54 %
52 Week High 485.00p
52 Week Low 327.50p
Volume 9,521
Shares Issued 47.52m
Market Cap £219.80m
Beta 0.01
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.76% below the market average97.76% below the market average97.76% below the market average97.76% below the market average97.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
81.81% above the market average81.81% above the market average81.81% above the market average81.81% above the market average81.81% above the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average
Income
83.92% below the market average83.92% below the market average83.92% below the market average83.92% below the market average83.92% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
17.61% above the market average17.61% above the market average17.61% above the market average17.61% above the market average17.61% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Mar-24 23-Nov-23
Paid 12-Apr-24 22-Dec-23
Amount 5.24p 7.88p

Trades for 01-May-2024

Time Volume / Share Price
15:11 225 @ 459.50p
14:15 3 @ 464.69p
14:13 258 @ 464.75p
14:12 248 @ 458.55p
14:04 335 @ 464.75p

Tristel Key Personnel

CEO Paul Christopher Swinney
Finance Director Elizabeth Dixon

Top of Page